Louis P. Perrault, MD, PhD, Alan J. Moskowitz, MD, Irving L

Slides:

Advertisements

Similar presentations

The “occasional open heart surgeon” revisited

Advertisements

Aortic valve replacement in low-flow, low-gradient aortic stenosis: Left ventricular ejection fraction matters Victor Dayan, MD, PhD, Philippe Pibarot,

Can papillary muscle interventions improve mitral valve repair durability for ischemic mitral regurgitation? Christos G. Mihos, DO, Orlando Santana,

Predicting recurrent mitral regurgitation after mitral valve repair for severe ischemic mitral regurgitation Irving L. Kron, MD, Judy Hung, MD, Jessica.

Moderate mitral regurgitation in aortic root replacement surgery: Comparing mitral repair with no mitral repair Fenton H. McCarthy, MD, Nimesh D. Desai,

The impact of placing multiple grafts to each myocardial territory on long-term survival after coronary artery bypass grafting Danny Chu, MD, Faisal.

Endoscopic Robotic Mitral Valve Surgery

The American Association for Thoracic Surgery 2016 Ethics Forum: Cost-effectiveness and the ethics of left ventricular assist device therapy John W.C.

Early mitral valve surgery for chronic severe mitral regurgitation optimizes left ventricular performance and left ventricular mass regression Ken-ichi.

Damien J. LaPar, MD, MSc, Carlos M. Mery, MD, MPH, Benjamin D

Serial multidetector computed tomography assessment of left ventricular reverse remodeling, mass, and regional wall stress after restrictive mitral annuloplasty.

Valve repair improves the outcome of surgery for chronic severe aortic regurgitation: A propensity score analysis Christophe de Meester, MS, Agnès Pasquet,

Puja Gaur, MD, Tsuyoshi Kaneko, MD, Siobhan McGurk, BS, James D

Stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: A meta-analysis of comparative studies Hisato Takagi,

Timing of valve repair for severe degenerative mitral regurgitation and long-term left ventricular function Takeshi Kitai, MD, Yukikatsu Okada, MD, Yu.

Right internal thoracic artery or saphenous vein grafting

Does preoperative carotid stenosis screening reduce perioperative stroke in patients undergoing coronary artery bypass grafting? Khalil Masabni, MD,

POINT: Efficacy of adding mitral valve restrictive annuloplasty to coronary artery bypass grafting in patients with moderate ischemic mitral valve regurgitation:

Design, rationale, and initiation of the Surgical Interventions for Moderate Ischemic Mitral Regurgitation Trial: A report from the Cardiothoracic Surgical.

Juan A. Crestanello, MD, Richard C. Daly, MD

A randomized comparison of the Saphenous Vein Versus Right Internal Thoracic Artery as a Y-Composite Graft (SAVE RITA) trial: Early results Ho Young.

Defining operative mortality: Impact on outcome reporting

Why surgery won the SYNTAX trial and why it matters

Marc R. Moon, MD The Journal of Thoracic and Cardiovascular Surgery

A new approach: Ischemic mitral regurgitation guidelines by and for surgeons Patrick M. McCarthy, MD The Journal of Thoracic and Cardiovascular Surgery

Functional mitral stenosis after mitral valve repair is a true anatomic problem that originates from the time of surgery Vincent Chan, MD, MPH, Thierry.

Multilevel data analysis: What? Why? How?

Harold L. Lazar, MD The Journal of Thoracic and Cardiovascular Surgery

Patrick T. O'Gara, MD, MACC, FAHA, Thoralf M. Sundt, MD, Michael A

Igor E. Konstantinov, MD, PhD, FRACS

Jared P. Beller, MD, Irving L. Kron, MD

Predicting recurrent mitral regurgitation after mitral valve repair: A difficult endeavor and a necessity Denis Bouchard, MD, Louis P. Perrault, MD,

Uniform standards do not apply to readmission following coronary artery bypass surgery: A multi-institutional study Robert Lancey, MD, Paul Kurlansky,

Surgical economics: MACRA, MIPS, and bundles—Lessons learned in the first 3 years of a coronary artery bypass grafting alternative payment model Daniel.

Baseline left ventricular function and surgical annular stiffening to predict outcome and reverse left ventricular remodeling after undersized annuloplasty.

The variability of the mitral valve anatomy and terminology

John V. Conte, MD The Journal of Thoracic and Cardiovascular Surgery

Does the degree of preoperative mitral regurgitation predict survival or the need for mitral valve repair or replacement in patients with anomalous origin.

Marta Kelava, MD, Michael Robich, MD, MSPH, Penny L

Transcatheter aortic valve replacement in intermediate-risk patients

Oh, father, where art we? Left internal mammary artery with greater saphenous vein grafts still rules surgical coronary revascularization after 30 years

The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery Vinay Badhwar, MD The Journal of Thoracic and.

Role of Surgical Ventricular Restoration in the Treatment of Ischemic Cardiomyopathy Jun Liu, MD, Zixiong Liu, MD, Qiang Zhao, MD, Anqing Chen, MD, Zhe.

Mitral valve repair in heart failure: Five-year follow-up from the mitral valve replacement stratum of the Acorn randomized trial Michael A. Acker, MD,

For everything there is a season

Transcatheter aortic valve replacement and surgical aortic valve replacement: Both excellent therapies J. James Edelman, MBBS(Hons), PhD, Vinod H. Thourani,

Surgery for aortic and mitral valve disease in the United States: A trend of change in surgical practice between 1998 and 2005 Scott D. Barnett, PhD,

Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD

Left ventricular dysfunction after degenerative mitral valve repair: A question of better molecular targets or better surgical timing? Jordan D. Miller,

Chronic obstructive pulmonary disease severity influences outcomes after off-pump coronary artery bypass Benjamin Medalion, MD, Michael G. Katz, MD,

Jeevanantham Rajeswaran, PhD, Eugene H. Blackstone, MD

The diabetes epidemic and its effect on cardiac surgery practice

Derrick Y. Tam, MD, Stephen E. Fremes, MD, MSc

Replicating the success of mitral valve repair in the aortic valve

The Ross procedure: Time to reevaluate the guidelines

Increased risk of dehiscence after tricuspid valve repair with rigid annuloplasty rings Bettina Pfannmüller, MD, Torsten Doenst, MD, PHD, Katja Eberhardt,

How much is enough to warrant prophylactic tricuspid repair?

Robotic mitral valve surgery: A United States multicenter trial

The Journal of Thoracic and Cardiovascular Surgery

Commentary: Three-dimensional P3 tethering angle at the heart of future surgical decision making in ischemic mitral regurgitation Wobbe Bouma, MD, PhD,

Shunt right or left? Decision 2016

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

The future of cardiac surgery training: A survival guide

Improved quality and cost-effectiveness of coronary artery bypass grafting in the United States from 1988 to 2005 Howard K. Song, MD, PhD, Brian S. Diggs,

Apples remain apples NO matter what

Of mice and men… The Journal of Thoracic and Cardiovascular Surgery

Chordal replacement with polytetrafluoroethylene sutures for mitral valve repair: A 25- year experience Tirone E. David, MD, Susan Armstrong, MSc, Joan.

Left Ventricular End-Diastolic Pressure Predicts Survival in Coronary Artery Bypass Graft Surgery Patients Jeevan Nagendran, MD, PhD, Colleen M. Norris,

IS local wound infection rate more important than long-term graft patency in coronary artery bypass grafting? Tomislav Kopjar, MD, PhD, Michael R. Dashwood,

Presentation transcript:

Optimal surgical management of severe ischemic mitral regurgitation: To repair or to replace? Louis P. Perrault, MD, PhD, Alan J. Moskowitz, MD, Irving L. Kron, MD, Michael A. Acker, MD, Marissa A. Miller, DVM, MPH, Keith A. Horvath, MD, Vinod H. Thourani, MD, Michael Argenziano, MD, David A. D’Alessandro, MD, Eugene H. Blackstone, MD, Claudia S. Moy, PhD, Joseph P. Mathew, MD, MHSc, Judy Hung, MD, Timothy J. Gardner, MD, Michael K. Parides, PhD The Journal of Thoracic and Cardiovascular Surgery Volume 143, Issue 6, Pages 1396-1403 (June 2012) DOI: 10.1016/j.jtcvs.2011.05.030 Copyright © 2012 Terms and Conditions

Figure 1 Severe mitral regurgitation trial design schematic. MR, Mitral regurgitation; CABG, coronary artery bypass grafting; LVESVI, left ventricular end-systolic volume index; QoL, quality of life; LOS, length of stay; LVEF, left ventricular ejection fraction; AEs, adverse events. The Journal of Thoracic and Cardiovascular Surgery 2012 143, 1396-1403DOI: (10.1016/j.jtcvs.2011.05.030) Copyright © 2012 Terms and Conditions